Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

HERA: the role of ovarian suppression in HR-positive HER2+ breast cancerПодробнее

The Changing Landscape for HER2+ Advanced Breast Cancer: Clinical Experience With Anti-HER2 AgentsПодробнее

ASCO 2023 | The evolving landscape in precision oncologyПодробнее

Understanding HER2-Low Breast Cancer: New Insights and Treatment OptionsПодробнее

Evolving Landscape of Targeted Therapies | Dr. Lizza HendriksПодробнее

Targeted Therapy for HER2 and HER3+ Breast Cancer: Navigating the Evolving Treatment LandscapeПодробнее

Changing landscape in the management of HER2 positive locally advanced and metastatic breast cancerПодробнее

New Perspectives on the Full Spectrum of HER2 Expression in Breast CancerПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Manage "Evolving Landscapes of HER-2 Negative Breast Cancer - 10 Dec"Подробнее

Options in Breast Cancer After HER2+ Targeted TherapyПодробнее

Evolving Treatment Landscape of R/R HER2+ mBCПодробнее

Targeted Therapy for HER2 & HER3-Positive Breast Cancer: Navigating the Evolving Treatment LandscapeПодробнее

Dr Justin Balko - "Immunophenotyping tumor infiltrating lymphocytes in breast cancer from.."Подробнее

Targeted Therapies in Lung Cancer Patient Forum - Evolving Landscape with Dr. Dara EisnerПодробнее

Keynote - Novel Therapeutics in Cancer (Jose Baselga)Подробнее

New Research in Metastatic Breast Cancer | SABCS 2019Подробнее